195 related articles for article (PubMed ID: 16908763)
1. Augmentation of myocardial production of 15-epi-lipoxin-a4 by pioglitazone and atorvastatin in the rat.
Birnbaum Y; Ye Y; Lin Y; Freeberg SY; Nishi SP; Martinez JD; Huang MH; Uretsky BF; Perez-Polo JR
Circulation; 2006 Aug; 114(9):929-35. PubMed ID: 16908763
[TBL] [Abstract][Full Text] [Related]
2. Aspirin augments 15-epi-lipoxin A4 production by lipopolysaccharide, but blocks the pioglitazone and atorvastatin induction of 15-epi-lipoxin A4 in the rat heart.
Birnbaum Y; Ye Y; Lin Y; Freeberg SY; Huang MH; Perez-Polo JR; Uretsky BF
Prostaglandins Other Lipid Mediat; 2007 Feb; 83(1-2):89-98. PubMed ID: 17259075
[TBL] [Abstract][Full Text] [Related]
3. Activation of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) by atorvastatin is mediated by 15-deoxy-delta-12,14-PGJ2.
Ye Y; Nishi SP; Manickavasagam S; Lin Y; Huang MH; Perez-Polo JR; Uretsky BF; Birnbaum Y
Prostaglandins Other Lipid Mediat; 2007 Aug; 84(1-2):43-53. PubMed ID: 17643887
[TBL] [Abstract][Full Text] [Related]
4. Myocardial protection by pioglitazone, atorvastatin, and their combination: mechanisms and possible interactions.
Ye Y; Lin Y; Atar S; Huang MH; Perez-Polo JR; Uretsky BF; Birnbaum Y
Am J Physiol Heart Circ Physiol; 2006 Sep; 291(3):H1158-69. PubMed ID: 16603698
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of 5-lipoxygenase at ser523 by protein kinase A determines whether pioglitazone and atorvastatin induce proinflammatory leukotriene B4 or anti-inflammatory 15-epi-lipoxin a4 production.
Ye Y; Lin Y; Perez-Polo JR; Uretsky BF; Ye Z; Tieu BC; Birnbaum Y
J Immunol; 2008 Sep; 181(5):3515-23. PubMed ID: 18714024
[TBL] [Abstract][Full Text] [Related]
6. Aspirin (ASA) regulates 5-lipoxygenase activity and peroxisome proliferator-activated receptor alpha-mediated CINC-1 release in rat liver cells: novel actions of lipoxin A4 (LXA4) and ASA-triggered 15-epi-LXA4.
Planagumà A; Titos E; López-Parra M; Gaya J; Pueyo G; Arroyo V; Clària J
FASEB J; 2002 Dec; 16(14):1937-9. PubMed ID: 12368230
[TBL] [Abstract][Full Text] [Related]
7. Aspirin has a gender-dependent impact on antiinflammatory 15-epi-lipoxin A4 formation: a randomized human trial.
Chiang N; Hurwitz S; Ridker PM; Serhan CN
Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):e14-7. PubMed ID: 16293793
[TBL] [Abstract][Full Text] [Related]
8. Antiinflammatory mediator lipoxin A4 and its receptor in synovitis of patients with rheumatoid arthritis.
Hashimoto A; Hayashi I; Murakami Y; Sato Y; Kitasato H; Matsushita R; Iizuka N; Urabe K; Itoman M; Hirohata S; Endo H
J Rheumatol; 2007 Nov; 34(11):2144-53. PubMed ID: 17918787
[TBL] [Abstract][Full Text] [Related]
9. Aspirin-triggered 15-epi-lipoxin A4 (ATL) generation by human leukocytes and murine peritonitis exudates: development of a specific 15-epi-LXA4 ELISA.
Chiang N; Takano T; Clish CB; Petasis NA; Tai HH; Serhan CN
J Pharmacol Exp Ther; 1998 Nov; 287(2):779-90. PubMed ID: 9808710
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 induced by zymosan in human monocyte-derived dendritic cells shows high stability, and its expression is enhanced by atorvastatin.
Alvarez Y; Municio C; Alonso S; San Román JA; Sánchez Crespo M; Fernández N
J Pharmacol Exp Ther; 2009 Jun; 329(3):987-94. PubMed ID: 19318593
[TBL] [Abstract][Full Text] [Related]
11. Atorvastatin reduces plaque vulnerability in an atherosclerotic rabbit model by altering the 5-lipoxygenase pathway.
Zhou G; Ge S; Liu D; Xu G; Zhang R; Yin Q; Zhu W; Chen J; Liu X
Cardiology; 2010; 115(3):221-8. PubMed ID: 20234134
[TBL] [Abstract][Full Text] [Related]
12. Protective role of cyclooxygenase (COX)-2 in experimental lung injury: evidence of a lipoxin A4-mediated effect.
Scully M; Gang C; Condron C; Bouchier-Hayes D; Cunningham AJ
J Surg Res; 2012 Jun; 175(1):176-84. PubMed ID: 21944479
[TBL] [Abstract][Full Text] [Related]
13. Myocardial 15-epi-lipoxin A4 generation provides a new mechanism for the immunomodulatory effects of statins and thiazolidinediones.
Levy BD
Circulation; 2006 Aug; 114(9):873-5. PubMed ID: 16940203
[No Abstract] [Full Text] [Related]
14. The effect of pioglitazone treatment on 15-epi-lipoxin A4 levels in patients with type 2 diabetes.
Gutierrez AD; Sathyanarayana P; Konduru S; Ye Y; Birnbaum Y; Bajaj M
Atherosclerosis; 2012 Jul; 223(1):204-8. PubMed ID: 22687642
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effect of atorvastatin on left ventricular remodeling in spontaneously hypertensive rats.
Kang L; Ge CJ; Hu SJ
Pharmacology; 2007; 80(2-3):120-6. PubMed ID: 17534121
[TBL] [Abstract][Full Text] [Related]
16. Treatment with atorvastatin partially protects the rat heart from harmful catecholamine effects.
Schmechel A; Grimm M; El-Armouche A; Höppner G; Schwoerer AP; Ehmke H; Eschenhagen T
Cardiovasc Res; 2009 Apr; 82(1):100-6. PubMed ID: 19136528
[TBL] [Abstract][Full Text] [Related]
17. Lipoxin A4 inhibits acute edema in mice: implications for the anti-edematogenic mechanism induced by aspirin.
Menezes-de-Lima O; Kassuya CA; Nascimento AF; Henriques Md; Calixto JB
Prostaglandins Other Lipid Mediat; 2006 Sep; 80(3-4):123-35. PubMed ID: 16939877
[TBL] [Abstract][Full Text] [Related]
18. Atorvastatin prevents connexin43 remodeling in hypertrophied left ventricular myocardium of spontaneously hypertensive rats.
Chen HJ; Yao L; Chen TG; Yu M; Wang LH; Chen JZ
Chin Med J (Engl); 2007 Nov; 120(21):1902-7. PubMed ID: 18067764
[TBL] [Abstract][Full Text] [Related]
19. Dual role of lipoxin A4 in pneumosepsis pathogenesis.
Sordi R; Menezes-de-Lima O; Horewicz V; Scheschowitsch K; Santos LF; Assreuy J
Int Immunopharmacol; 2013 Oct; 17(2):283-92. PubMed ID: 23816538
[TBL] [Abstract][Full Text] [Related]
20. Preeclampsia is associated with a deficiency of lipoxin A4, an endogenous anti-inflammatory mediator.
Xu Z; Zhao F; Lin F; Xiang H; Wang N; Ye D; Huang Y
Fertil Steril; 2014 Jul; 102(1):282-290.e4. PubMed ID: 24796762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
